Association of National Eye Institute Visual Function Questionnaire 39 Scores With Visual Function in Age-related Macular Degeneration Over 24 Months

Background and Objective The aim of this study was to determine the National Eye Institute Visual Function Questionnaire 39 (NEI-VFQ39) score association with visual function (VF) tests in early (eAMD) and intermediate (iAMD) age-related macular degeneration. Patients and Methods Thirty-three eAMD,...

Full description

Saved in:
Bibliographic Details
Published inOphthalmic surgery, lasers & imaging pp. 1 - 8
Main Authors Yao, Catherine S, Lue, Victoria, Stinnett, Sandra S., Luhmann, Ulrich F.O., Lad, Eleonora M.
Format Journal Article
LanguageEnglish
Published Thorofare, NJ SLACK Incorporated 01.08.2025
Slack, Inc
SLACK INCORPORATED
Subjects
Age
Age related diseases
Dark adaptation
Disease
Eye diseases
Eye movements
Macular degeneration
Mann-Whitney U test
Patients
Physiological aspects
Political aspects
Questionnaires
Visual acuity
Visual impairment
Online AccessGet full text

Cover

Abstract Background and Objective The aim of this study was to determine the National Eye Institute Visual Function Questionnaire 39 (NEI-VFQ39) score association with visual function (VF) tests in early (eAMD) and intermediate (iAMD) age-related macular degeneration. Patients and Methods Thirty-three eAMD, 47 iAMD, 21 control subjects completed the NEIVFQ39 at baseline and 22 eAMD, 31 iAMD, 17 control subjects at 24 months. Best-corrected visual acuity (BCVA), low luminance visual acuity (LLVA), cone contrast test (CCT), microperimetry (MP) with eye-tracking (MAIA), and dark adaptation (DA) testing were administered during both visits. Results At baseline and 24 months, iAMD patients scored lower NEI-VFQ39 composite scores than eAMD participants and controls (P < 0.05); longitudinal changes showed no differences between groups. Baseline composite scores were associated with LLVA (Spearman-r = 0.33, P < 0.001), percent-reduced threshold (PRT) (r = −0.33, P = 0.001), and absolute threshold (AT) (r = 0.31, P = 0.003) on MP. Conclusion Although the NEI-VFQ39 did not detect change over 24 months, these results support the use of NEI-VFQ39 as a cross-sectional tool in iAMD.
AbstractList Background and Objective The aim of this study was to determine the National Eye Institute Visual Function Questionnaire 39 (NEI-VFQ39) score association with visual function (VF) tests in early (eAMD) and intermediate (iAMD) age-related macular degeneration. Patients and Methods Thirty-three eAMD, 47 iAMD, 21 control subjects completed the NEIVFQ39 at baseline and 22 eAMD, 31 iAMD, 17 control subjects at 24 months. Best-corrected visual acuity (BCVA), low luminance visual acuity (LLVA), cone contrast test (CCT), microperimetry (MP) with eye-tracking (MAIA), and dark adaptation (DA) testing were administered during both visits. Results At baseline and 24 months, iAMD patients scored lower NEI-VFQ39 composite scores than eAMD participants and controls (P < 0.05); longitudinal changes showed no differences between groups. Baseline composite scores were associated with LLVA (Spearman-r = 0.33, P < 0.001), percent-reduced threshold (PRT) (r = −0.33, P = 0.001), and absolute threshold (AT) (r = 0.31, P = 0.003) on MP. Conclusion Although the NEI-VFQ39 did not detect change over 24 months, these results support the use of NEI-VFQ39 as a cross-sectional tool in iAMD.
The aim of this study was to determine the National Eye Institute Visual Function Questionnaire 39 (NEI-VFQ39) score association with visual function (VF) tests in early (eAMD) and intermediate (iAMD) age-related macular degeneration. Thirty-three eAMD, 47 iAMD, 21 control subjects completed the NEIVFQ39 at baseline and 22 eAMD, 31 iAMD, 17 control subjects at 24 months. Best-corrected visual acuity (BCVA), low luminance visual acuity (LLVA), cone contrast test (CCT), microperimetry (MP) with eye-tracking (MAIA), and dark adaptation (DA) testing were administered during both visits. At baseline and 24 months, iAMD patients scored lower NEI-VFQ39 composite scores than eAMD participants and controls ( < 0.05); longitudinal changes showed no differences between groups. Baseline composite scores were associated with LLVA (Spearman- = 0.33, < 0.001), percent-reduced threshold (PRT) ( = -0.33, = 0.001), and absolute threshold (AT) ( = 0.31, = 0.003) on MP. Although the NEI-VFQ39 did not detect change over 24 months, these results support the use of NEI-VFQ39 as a cross-sectional tool in iAMD.
The aim of this study was to determine the National Eye Institute Visual Function Questionnaire 39 (NEI-VFQ39) score association with visual function (VF) tests in early (eAMD) and intermediate (iAMD) age-related macular degeneration. Thirty-three eAMD, 47 iAMD, 21 control subjects completed the NEIVFQ39 at baseline and 22 eAMD, 31 iAMD, 17 control subjects at 24 months. Best-corrected visual acuity (BCVA), low luminance visual acuity (LLVA), cone contrast test (CCT), microperimetry (MP) with eye-tracking (MAIA), and dark adaptation (DA) testing were administered during both visits. At baseline and 24 months, iAMD patients scored lower NEI-VFQ39 composite scores than eAMD participants and controls (P < 0.05); longitudinal changes showed no differences between groups. Baseline composite scores were associated with LLVA (Spearman-r = 0.33, P < 0.001), percent-reduced threshold (PRT) (r = −0.33, P = 0.001), and absolute threshold (AT) (r = 0.31, P = 0.003) on MP. Although the NEI-VFQ39 did not detect change over 24 months, these results support the use of NEI-VFQ39 as a cross-sectional tool in iAMD.
Background and Objective The aim of this study was to determine the National Eye Institute Visual Function Questionnaire 39 (NEI-VFQ39) score association with visual function (VF) tests in early (eAMD) and intermediate (iAMD) age-related macular degeneration. Patients and Methods Thirty-three eAMD, 47 iAMD, 21 control subjects completed the NEIVFQ39 at baseline and 22 eAMD, 31 iAMD, 17 control subjects at 24 months. Best-corrected visual acuity (BCVA), low luminance visual acuity (LLVA), cone contrast test (CCT), microperimetry (MP) with eye-tracking (MAIA), and dark adaptation (DA) testing were administered during both visits. Results At baseline and 24 months, iAMD patients scored lower NEI-VFQ39 composite scores than eAMD participants and controls (P < 0.05); longitudinal changes showed no differences between groups. Baseline composite scores were associated with LLVA (Spearman-r = 0.33, P < 0.001), percent-reduced threshold (PRT) (r = −0.33, P = 0.001), and absolute threshold (AT) (r = 0.31, P = 0.003) on MP. Conclusion Although the NEI-VFQ39 did not detect change over 24 months, these results support the use of NEI-VFQ39 as a cross-sectional tool in iAMD.
The aim of this study was to determine the National Eye Institute Visual Function Questionnaire 39 (NEI-VFQ39) score association with visual function (VF) tests in early (eAMD) and intermediate (iAMD) age-related macular degeneration.BACKGROUND AND OBJECTIVEThe aim of this study was to determine the National Eye Institute Visual Function Questionnaire 39 (NEI-VFQ39) score association with visual function (VF) tests in early (eAMD) and intermediate (iAMD) age-related macular degeneration.Thirty-three eAMD, 47 iAMD, 21 control subjects completed the NEIVFQ39 at baseline and 22 eAMD, 31 iAMD, 17 control subjects at 24 months. Best-corrected visual acuity (BCVA), low luminance visual acuity (LLVA), cone contrast test (CCT), microperimetry (MP) with eye-tracking (MAIA), and dark adaptation (DA) testing were administered during both visits.PATIENTS AND METHODSThirty-three eAMD, 47 iAMD, 21 control subjects completed the NEIVFQ39 at baseline and 22 eAMD, 31 iAMD, 17 control subjects at 24 months. Best-corrected visual acuity (BCVA), low luminance visual acuity (LLVA), cone contrast test (CCT), microperimetry (MP) with eye-tracking (MAIA), and dark adaptation (DA) testing were administered during both visits.At baseline and 24 months, iAMD patients scored lower NEI-VFQ39 composite scores than eAMD participants and controls (P < 0.05); longitudinal changes showed no differences between groups. Baseline composite scores were associated with LLVA (Spearman-r = 0.33, P < 0.001), percent-reduced threshold (PRT) (r = -0.33, P = 0.001), and absolute threshold (AT) (r = 0.31, P = 0.003) on MP.RESULTSAt baseline and 24 months, iAMD patients scored lower NEI-VFQ39 composite scores than eAMD participants and controls (P < 0.05); longitudinal changes showed no differences between groups. Baseline composite scores were associated with LLVA (Spearman-r = 0.33, P < 0.001), percent-reduced threshold (PRT) (r = -0.33, P = 0.001), and absolute threshold (AT) (r = 0.31, P = 0.003) on MP.Although the NEI-VFQ39 did not detect change over 24 months, these results support the use of NEI-VFQ39 as a cross-sectional tool in iAMD.CONCLUSIONAlthough the NEI-VFQ39 did not detect change over 24 months, these results support the use of NEI-VFQ39 as a cross-sectional tool in iAMD.
Audience Academic
Author Yao, Catherine S
Luhmann, Ulrich F.O.
Stinnett, Sandra S.
Lue, Victoria
Lad, Eleonora M.
Author_xml – sequence: 1
  givenname: Catherine S
  surname: Yao
  fullname: Yao, Catherine S
  email: cyao15@jh.edu
– sequence: 2
  givenname: Victoria
  surname: Lue
  fullname: Lue, Victoria
– sequence: 3
  givenname: Sandra S.
  surname: Stinnett
  fullname: Stinnett, Sandra S.
– sequence: 4
  givenname: Ulrich F.O.
  surname: Luhmann
  fullname: Luhmann, Ulrich F.O.
– sequence: 5
  givenname: Eleonora M.
  surname: Lad
  fullname: Lad, Eleonora M.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40788856$$D View this record in MEDLINE/PubMed
BookMark eNp9kltPFTEQxzcGI4h8A2OamBhfFnvbtvt4gqAkIDHeHjelOz2n2NNCu2vCB_H72mU5IGpsHzqZ_P4zncvTaivEAFX1nOB91lL1hjLaKCJwTTFtsCSyxuRRtTO5a0Vku3VnC7xd7eV8gctRVBCMn1TbHEulVCN2qp-LnKNxenAxoGjRhxtLe3R4Deg45MEN4wDoq8tjcR6NwdyQH0fIkxG0S4BYiz6ZmCCjb25Y_QW7gBZLqBN4PUCPTrUZvU7oLSwhQJpTn_2AhChHpzEMq_ysemy1z7B3--5WX44OPx-8r0_O3h0fLE5qQyUmNesbJc4tSLCYEjC2UbSxhDWa9lxp0oiW91gTrjCXWljSt8z2hrKecGwlZ7vV6znuZYpXU0nd2mUD3usAccwdo0xJIlqiCvryD_Qijql0aqZYIwXH99RSe-hcsHFI2kxBu4VqCFVYCFmo_X9Q5fawdqZM2rrifyB49ZtgBdqXJkU_Tq3LD8EXt78cz9fQd5fJrXW67jYDLwCfAZNizgnsHUJwN61Wt1mtbrNaHSZFRmdZ9tp8vy_9v6Jf2bbLjA
Cites_doi 10.1167/iovs.10-5645
10.1167/iovs.11-8649
10.1186/s13023-018-0810-x
10.1016/S2214-109X(13)70113-X
10.2147/PROM.S156279
10.1167/iovs.09-4494
10.1167/iovs.08-3225
10.1016/S2214-109X(13)70145-1
10.1016/S0002-9394(99)00108-7
10.1001/archopht.119.7.1050
10.1016/j.ajo.2018.02.012
10.1111/aos.14731
10.1097/IAE.0000000000001002
10.1016/S1470-2045(18)30097-4
10.2147/PROM.S162802
10.1159/000491402
10.1016/j.ddstr.2012.11.002
10.23750/abm.v91i3.10079
10.1167/iovs.12-9813
10.1186/s12955-019-1203-0
10.1186/s12886-021-01901-x
10.1038/s41598-019-51769-7
10.1016/j.ophtha.2010.01.059
10.1016/S0161-6420(02)01060-6
10.1167/iovs.17-22528
10.1016/j.xops.2022.100173
10.1167/iovs.05-1222
10.1001/archopht.116.11.1496
10.1016/j.jcrs.2009.11.019
10.1136/bjophthalmol-2014-306544
10.2147/OPTH.S338253
10.2147/CIA.S142685
10.1001/archopht.123.9.1207
10.1016/j.neuron.2012.06.018
10.1167/iovs.09-3766
ContentType Journal Article
Copyright Copyright 2025, SLACK Incorporated
COPYRIGHT 2025 Slack, Inc.
Copyright_xml – notice: Copyright 2025, SLACK Incorporated
– notice: COPYRIGHT 2025 Slack, Inc.
DBID AAYXX
CITATION
NPM
3V.
7RQ
7X7
7XB
88E
88I
8AF
8FE
8FG
8FI
8FJ
8FK
ABJCF
ABUWG
AFKRA
ARAPS
AZQEC
BENPR
BGLVJ
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
L6V
M0S
M1P
M2P
M7S
P5Z
P62
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PTHSS
Q9U
S0X
U9A
7X8
DOI 10.3928/23258160-20250717-01
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Career & Technical Education Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
STEM Database
ProQuest SciTech Collection
ProQuest Technology Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
ProQuest Central
Technology Collection
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Engineering Collection
ProQuest Health & Medical Collection
Medical Database
Science Database
Engineering Database
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
Engineering Collection
ProQuest Central Basic
SIRS Editorial
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
ProQuest Central Student
Technology Collection
ProQuest One Academic Middle East (New)
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
SIRS Editorial
ProQuest Health & Medical Complete (Alumni)
ProQuest AP Science
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
ProQuest Engineering Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Career and Technical Education (Alumni Edition)
Advanced Technologies & Aerospace Collection
Engineering Database
ProQuest Science Journals (Alumni Edition)
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Advanced Technologies & Aerospace Database
ProQuest Career and Technical Education
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Materials Science & Engineering Collection
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Central Student
PubMed




MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2325-8179
EndPage 8
ExternalDocumentID A851280667
40788856
10_3928_23258160_20250717_01
Genre research-article
Clinical Science
Journal Article
GroupedDBID 4.4
7RQ
7X7
88E
88I
8AF
8FE
8FG
8FI
8FJ
ABJCF
ABUWG
ACGFS
ACGOD
ACIWK
ADBBV
AFKRA
AHMBA
ALMA_UNASSIGNED_HOLDINGS
ARAPS
AZQEC
BENPR
BGLVJ
BPHCQ
BVXVI
C45
CCPQU
DWQXO
EBS
EMOBN
FYUFA
GNUQQ
HCIFZ
HMCUK
IAO
IHR
IHW
ITC
L6V
M1P
M2P
M2Q
M7S
OVD
P62
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PTHSS
RWG
S0X
SJN
TEORI
UKHRP
AAYXX
ALIPV
CITATION
NPM
---
123
29N
36B
3V.
53G
7XB
8FK
ACGFO
EMB
F5P
K9.
L7B
PKEHL
PQEST
PQUKI
Q9U
RWL
SV3
TAE
U9A
7X8
ID FETCH-LOGICAL-c2701-3d586bfe7ef021ecf5825f135a2d48a15694d0a148047a6f1d93fdc23d140f743
IEDL.DBID 7X7
ISSN 2325-8160
2325-8179
IngestDate Tue Aug 12 16:32:09 EDT 2025
Mon Aug 11 15:41:07 EDT 2025
Wed Aug 13 23:48:09 EDT 2025
Tue Aug 19 03:41:24 EDT 2025
Tue Aug 19 02:11:08 EDT 2025
Wed Aug 13 02:15:29 EDT 2025
Thu Aug 14 00:03:40 EDT 2025
Thu Aug 21 14:13:15 EDT 2025
IsPeerReviewed true
IsScholarly true
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2701-3d586bfe7ef021ecf5825f135a2d48a15694d0a148047a6f1d93fdc23d140f743
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 40788856
PQID 3238357640
PQPubID 13886
PageCount 8
ParticipantIDs proquest_miscellaneous_3238716918
proquest_journals_3238357640
gale_infotracmisc_A851280667
gale_infotracacademiconefile_A851280667
gale_healthsolutions_A851280667
pubmed_primary_40788856
crossref_primary_10_3928_23258160_20250717_01
slack_journals_10_3928_23258160_20250717_01
PublicationCentury 2000
PublicationDate 20250801
PublicationDateYYYYMMDD 2025-08-01
PublicationDate_xml – month: 08
  year: 2025
  text: 20250801
  day: 01
PublicationDecade 2020
PublicationPlace Thorofare, NJ
PublicationPlace_xml – name: Thorofare, NJ
– name: United States
– name: Thorofare
PublicationTitle Ophthalmic surgery, lasers & imaging
PublicationTitleAbbrev Ophthalmic Surg Lasers Imaging Retina
PublicationTitleAlternate Ophthalmic Surg Lasers Imaging Retina
PublicationYear 2025
Publisher SLACK Incorporated
Slack, Inc
SLACK INCORPORATED
Publisher_xml – name: SLACK Incorporated
– name: Slack, Inc
– name: SLACK INCORPORATED
References e_1_3_1_21_2
e_1_3_1_22_2
e_1_3_1_23_2
e_1_3_1_24_2
Curcio CA (e_1_3_1_35_2) 1993; 34
e_1_3_1_8_2
e_1_3_1_7_2
e_1_3_1_40_2
e_1_3_1_41_2
e_1_3_1_9_2
e_1_3_1_20_2
e_1_3_1_4_2
e_1_3_1_3_2
e_1_3_1_6_2
e_1_3_1_5_2
e_1_3_1_25_2
e_1_3_1_2_2
e_1_3_1_27_2
e_1_3_1_28_2
Patnaik J (e_1_3_1_29_2) 2019; 60
National Eye Institute (e_1_3_1_26_2) 2000
e_1_3_1_34_2
e_1_3_1_13_2
e_1_3_1_12_2
e_1_3_1_11_2
e_1_3_1_30_2
e_1_3_1_10_2
e_1_3_1_31_2
Curcio CA (e_1_3_1_32_2) 1996; 37
e_1_3_1_17_2
e_1_3_1_16_2
e_1_3_1_15_2
e_1_3_1_14_2
e_1_3_1_36_2
e_1_3_1_37_2
e_1_3_1_19_2
Owsley C (e_1_3_1_33_2) 2000; 41
e_1_3_1_38_2
e_1_3_1_18_2
e_1_3_1_39_2
References_xml – ident: e_1_3_1_37_2
  doi: 10.1167/iovs.10-5645
– ident: e_1_3_1_9_2
  doi: 10.1167/iovs.11-8649
– ident: e_1_3_1_15_2
  doi: 10.1186/s13023-018-0810-x
– ident: e_1_3_1_4_2
  doi: 10.1016/S2214-109X(13)70113-X
– ident: e_1_3_1_14_2
  doi: 10.2147/PROM.S156279
– ident: e_1_3_1_27_2
  doi: 10.1167/iovs.09-4494
– ident: e_1_3_1_28_2
  doi: 10.1167/iovs.08-3225
– ident: e_1_3_1_5_2
  doi: 10.1016/S2214-109X(13)70145-1
– ident: e_1_3_1_6_2
  doi: 10.1016/S0002-9394(99)00108-7
– ident: e_1_3_1_20_2
  doi: 10.1001/archopht.119.7.1050
– ident: e_1_3_1_25_2
  doi: 10.1016/j.ajo.2018.02.012
– volume: 41
  start-page: 267
  issue: 1
  year: 2000
  ident: e_1_3_1_33_2
  article-title: Psychophysical evidence for rod vulnerability in age-related macular degeneration
  publication-title: Invest Ophthalmol Vis Sci
– ident: e_1_3_1_31_2
  doi: 10.1111/aos.14731
– ident: e_1_3_1_10_2
  doi: 10.1097/IAE.0000000000001002
– ident: e_1_3_1_16_2
  doi: 10.1016/S1470-2045(18)30097-4
– volume-title: Visual Function Questionnaire 25
  year: 2000
  ident: e_1_3_1_26_2
– ident: e_1_3_1_13_2
  doi: 10.2147/PROM.S162802
– ident: e_1_3_1_21_2
  doi: 10.1159/000491402
– ident: e_1_3_1_12_2
  doi: 10.1016/j.ddstr.2012.11.002
– ident: e_1_3_1_3_2
  doi: 10.23750/abm.v91i3.10079
– ident: e_1_3_1_24_2
  doi: 10.1167/iovs.12-9813
– volume: 34
  start-page: 3278
  issue: 12
  year: 1993
  ident: e_1_3_1_35_2
  article-title: Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina
  publication-title: Invest Ophthalmol Vis Sci
– ident: e_1_3_1_40_2
  doi: 10.1186/s12955-019-1203-0
– volume: 60
  start-page: 67
  issue: 9
  year: 2019
  ident: e_1_3_1_29_2
  article-title: The National Eye Institute Visual Function Questionnaire-25 in patients with age-related macular degeneration and controls
  publication-title: Invest Ophthalmol Vis Sci
– ident: e_1_3_1_34_2
  doi: 10.1186/s12886-021-01901-x
– ident: e_1_3_1_18_2
  doi: 10.1038/s41598-019-51769-7
– ident: e_1_3_1_39_2
  doi: 10.1016/j.ophtha.2010.01.059
– ident: e_1_3_1_7_2
  doi: 10.1016/S0161-6420(02)01060-6
– ident: e_1_3_1_19_2
  doi: 10.1167/iovs.17-22528
– ident: e_1_3_1_23_2
  doi: 10.1016/j.xops.2022.100173
– ident: e_1_3_1_8_2
  doi: 10.1167/iovs.05-1222
– ident: e_1_3_1_11_2
  doi: 10.1001/archopht.116.11.1496
– ident: e_1_3_1_38_2
  doi: 10.1016/j.jcrs.2009.11.019
– ident: e_1_3_1_17_2
  doi: 10.1136/bjophthalmol-2014-306544
– ident: e_1_3_1_22_2
  doi: 10.2147/OPTH.S338253
– volume: 37
  start-page: 1236
  issue: 7
  year: 1996
  ident: e_1_3_1_32_2
  article-title: Photoreceptor loss in age-related macular degeneration
  publication-title: Invest Ophthalmol Vis Sci
– ident: e_1_3_1_41_2
  doi: 10.2147/CIA.S142685
– ident: e_1_3_1_30_2
  doi: 10.1001/archopht.123.9.1207
– ident: e_1_3_1_2_2
  doi: 10.1016/j.neuron.2012.06.018
– ident: e_1_3_1_36_2
  doi: 10.1167/iovs.09-3766
SSID ssj0000826100
ssj0021135
ssj0000696753
Score 2.3975055
SecondaryResourceType online_first
Snippet Background and Objective The aim of this study was to determine the National Eye Institute Visual Function Questionnaire 39 (NEI-VFQ39) score association with...
The aim of this study was to determine the National Eye Institute Visual Function Questionnaire 39 (NEI-VFQ39) score association with visual function (VF)...
Background and Objective The aim of this study was to determine the National Eye Institute Visual Function Questionnaire 39 (NEI-VFQ39) score association with...
SourceID proquest
gale
pubmed
crossref
slack
SourceType Aggregation Database
Index Database
Publisher
StartPage 1
SubjectTerms Age
Age related diseases
Dark adaptation
Disease
Eye diseases
Eye movements
Macular degeneration
Mann-Whitney U test
Patients
Physiological aspects
Political aspects
Questionnaires
Visual acuity
Visual impairment
Title Association of National Eye Institute Visual Function Questionnaire 39 Scores With Visual Function in Age-related Macular Degeneration Over 24 Months
URI https://journals.healio.com/doi/10.3928/23258160-20250717-01
https://www.ncbi.nlm.nih.gov/pubmed/40788856
https://www.proquest.com/docview/3238357640
https://www.proquest.com/docview/3238716918
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagKyEuiHdTSjESEgdkNQ_bcU5ogV0qpBYEFPYWOY7droSybZM98EP4v8w4TroLUi_RypmsEs_rm_F4TMgrDoKSuzxhVQIXLp1lqso4q4WxBvxvZqwvkD2RR6f800IsQsKtDWWVg030hrpeGcyRH2bgWzIAxzx-e3HJ8NQoXF0NR2jcJhNsXYYlXfkiH3MssSykh-MhAEv6AzcBRAimEhn3W-kAIahDHMMhkJoUIRLWY265qn8N9obHmrSYa9twS_P75F7Ak3TaC8ADcss2D8md47Bi_oj82Zh_unI09MH-RWe_LR0rBeiPZbuGwTl4OU_p86Dwo9FgEmlW0G_Y7rKlP5fd-X_Ey4ZOzyzz22JsTY-1r22lH-yZ72ntaT6DytCUU7Ah3Xn7mJzOZ9_fH7FwFAMzaR4nLKuFkpWzuXUwjdY4AZGlg-nUac2VhiCw4HWsIbaKea6lS-oic7VJsxoCOAco5QnZaVaN3SXUcQGGQ2tRmYwXeVJYKyqpLDwihHI2ImyY9fKi77hRQqSCXCoHLpUDl8o4icgLZE3Z7xsdFbacApbEZWOZR-S1p0CV7a600WHnAbwPNr_aotzfogRVM9u3B_aXQdXb8lowI_JyvI1PYvlaY1frnsa3JVIRedqLzfhtuJCqlJAReePl6Pqfb_rqvZtf5Rm5i8R9peI-2emu1vY5oKeuOvAqAlc1_3hAJu9mJ1--_gUg2BEu
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VVgIuiDcphRoJxAFFTeJHnANCK9plS7vlQAu9GSex25WqbGmyQv0h_A1-I2Mn2e6C1Fsvq5UzjpLM45uxZ8YArxkKSmrTOMxj_GHCmlDmlIUlL0yB-EsL4xNkD8ToiH0-5scr8KevhXFplb1N9Ia6nBZujXyLIrZQdI5Z9OH8Z-hOjXK7q_0RGq1Y7JnLXxiy1e93t5G_b5JkuHP4cRR2pwqERZJi7ExLLkVuTWos4pspLMcgycaU66RkUmM8k7Ey0hgmRCzVwsZlRm1ZJLTEWMQi4OJ9b8EaozRzGiWHn-ZrOpHIhHf_u4Avbg_4RKeFhzIWUVu6hx6J3HJjbgilNHEumcv_XILGfwFiASHXare2twCDw_twr_NfyaAVuAewYqqHcHvc7dA_gt8L_CZTS7q-22dk59KQeWYC-TapZzg4RFT1lH7dFf9UGk0woRn56tpr1uT7pDn9j3hSkcGJCX0ZjinJWPtcWrJtTnwPbU_zBVWUJIygzWpO68dwdCNMegKr1bQyz4BYxtFQac3zgrIsjTNjeC6kwSmcS2sCCPuvrs7bDh8KIyPHJdVzSfVcUlEcwKZjjWrrVOcGQg3Qd3Xb1CIN4K2ncCaiudCF7iod8Hlcs60lyo0lSlTtYvlyz37VmZZaXSlCAK_ml91Mly5XmemspfFtkGQAT1uxmb-b27iVkosA3nk5urrzdW-9fv2jbMKd0eF4X-3vHuw9h7tuYpsluQGrzcXMvEDPrclfenUh8OOm9fMvlGpKYg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVqq4IN64FLpIIA7Iiu19-oBQRBq1lBYkKORm1vZuGwk5bZ0I9YfwZ_h1zK4fTUDqrZcoWs9atufxzezOzAK8ZCgo0so4zGP8YcKaUOWUhSUvTIH4SwvjE2SPxN4x-zDhkzX409XCuLTKziZ6Q13OCrdGPqCILRSdYxYNbJsW8Xk0fnd2HroTpNxOa3ecRiMiB-byF4Zv9dv9EfL6VZKMd7--3wvbEwbCIpEYR9OSK5FbI41FrDOF5Rgw2ZhynZRMaYxtUlZGGkOGiEktbFym1JZFQkuMSyyCL973FmxIymOnY3Ii-_WdSKTChwJt8Bc3h32iA8NDFYuoKeND70QN3JgbQolNnHvmckFXYPJfsFhCy43arfMtQeL4LtxpfVkybITvHqyZ6j5sHra79Q_g9xLvycyStgf3T7J7aUifpUC-TesFDo4RYT2lX4PFP5VGc0xoSr64Vps1-T6dn_5HPK3I8MSEviTHlORQ-7xaMjInvp-2p_mE6koSRtB-zU_rh3B8I0x6BOvVrDJPgFjG0WhpzfOCslTGqTE8F8rgFM6VNQGE3VfPzppuHxlGSY5LWcelrONSFsUB7DjWZE3Nam8ssiH6sW7LWsgAXnsKZy7mF7rQbdUDPo9rvLVCub1CiWperF7u2J-1ZqbOrpQigBf9ZTfTpc5VZrZoaHxLJBXA40Zs-ndzm7hKcRHAGy9HV3e-7q23rn-UHdhEzcw-7h8dPIXbbl6TMLkN6_OLhXmGTtw8f-61hcCPm1bPv2SFTo8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+National+Eye+Institute+Visual+Function+Questionnaire+39+Scores+With+Visual+Function+in+Age-related+Macular+Degeneration+Over+24+Months&rft.jtitle=Ophthalmic+surgery%2C+lasers+%26+imaging+retina&rft.au=Yao%2C+Catherine+S&rft.au=Lue%2C+Victoria&rft.au=Stinnett%2C+Sandra+S.&rft.au=Luhmann%2C+Ulrich+F.O.&rft.date=2025-08-01&rft.pub=SLACK+Incorporated&rft.issn=2325-8160&rft.eissn=2325-8179&rft.spage=1&rft.epage=8&rft_id=info:doi/10.3928%2F23258160-20250717-01&rft.externalDBID=n%2Fa
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2325-8160&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2325-8160&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2325-8160&client=summon